Related Experiment Video

Updated: Apr 14, 2026

Facile Preparation of 4-Substituted Quinazoline Derivatives
11:51

Facile Preparation of 4-Substituted Quinazoline Derivatives

Published on: February 15, 2016

12.5K

Pyrroloquinoline quinone scaffolds: centrality in anticancer drug design

Siuli Sen1, Dipanjan Karati1

  • 1Department of Pharmaceutical Technology, School of Pharmacy, Techno India University, Kolkata, India.

Future Medicinal Chemistry
|April 13, 2026
PubMed

Insights

Pyrroloquinoline Quinone (PQQ) shows anticancer potential in preclinical studies. Further clinical research is needed to explore its efficacy and optimize its use in cancer treatment.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Pyrroloquinoline Quinone (PQQ) is a redox-active molecule with demonstrated health implications.
  • Preclinical research suggests PQQ possesses anticancer properties through various molecular pathways.
  • Current clinical evidence for PQQ in oncology is limited, with investigations primarily focusing on its use as a dietary supplement.

Purpose of the Study:

  • To highlight the potential of Pyrroloquinoline Quinone (PQQ) in cancer therapy.
  • To underscore the need for clinical trials to evaluate PQQ's anticancer efficacy.
  • To identify future research directions for advancing PQQ in oncology.

Main Methods:

  • Review of preclinical studies on PQQ's anticancer mechanisms.
  • Analysis of existing clinical investigations of PQQ as a dietary supplement.
  • Identification of opportunities for translational research in cancer.

Main Results:

  • PQQ exhibits anticancer properties via multiple molecular pathways in preclinical models.
  • Clinical studies have predominantly assessed PQQ disodium salt as a dietary supplement.
  • PQQ has a known safety profile and standardized formulations are available.

Conclusions:

  • The established safety and formulation of PQQ present an opportunity for its advancement into cancer research.
  • Future research should focus on in vivo tumor models, combination therapies, enhanced delivery, and biomarker discovery.
  • Translational studies are crucial to determine PQQ's clinical utility in oncology.
Keywords:
MAPKNF-κBPyrroloquinoline quinoneSAR Studycancer

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

2.1K
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.6K

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.4K
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
5.4K
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
84
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K